Incyte (INCY) officer sells 769 shares, holds 23,573 post‑trade
Incyte Corporation (INCY) reported insider stock transactions by its Principal Accounting Officer on a Form 4.
Rhea-AI Filing Summary
Incyte Corporation (INCY) reported insider stock transactions by its Principal Accounting Officer on a Form 4. The officer sold 169 shares of common stock on 11/21/2025 at $102 per share and 600 shares on 11/24/2025 at $103 per share. After these sales, the officer directly owned 23,573 shares of Incyte common stock.
The filing also notes that, including a July 15, 2025 grant, the officer holds an aggregate of 15,166 shares of common stock issuable from previously reported restricted stock units that have not yet vested. These transactions reflect personal trading activity by a company officer and ongoing equity-based compensation.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 600 | $103.00 | $62K |
| Sale | Common Stock | 169 | $102.00 | $17K |
Footnotes (1)
- F1. Including the July 15, 2025 grant, this includes an aggregate of 15,166 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
FAQ
What insider transaction did Incyte (INCY) report in this Form 4?
What equity awards are still unvested for the Incyte (INCY) officer?
What is the reporting person’s role at Incyte (INCY)?
Is this Incyte (INCY) Form 4 filed for one person or multiple insiders?
AI-generated analysis. How Rhea-AI works. Not financial advice.